Advertisement

Topics

HELSINN HEALTHCARE S.A. Company Profile

13:57 EDT 21st September 2018 | BioPortfolio

Helsinn's strategy is focused on three activities Integrated Licensing Helsinn uses an innovative approach to develop and market new pharmaceutical products:
INTEGRATED LICENSING
Helsinn adds scientific and market value to its products.
Integrated Manufacturing Helsinn is a qualified developer and producer of Active Pharmaceutical Ingredients (APIs), High Potency Active Ingredients (HPAIs) and finished dosage forms.
Helsinn delivers a ready-to-market product to its partners.
Pharmaceutical Business
Helsinn is engaged in local sales and marketing in the Irish market with two sales teams.

Location

via Pian Scairolo 9
Pazzallo
6912
Switzerland

Contact

Phone: 41 91 985.21.21
Fax: 41 91 993.21.22


News Articles [385 Associated News Articles listed on BioPortfolio]

Helsinn Healthcare SA Mergers Acquisitions MA, Partnerships Alliances and Investments [Report Updated: 23042018] Prices from USD $350

Helsinn Healthcare SA Mergers Acquisitions MA, Partnerships Alliances and InvestmentsSummaryMarketline's Helsinn Healthcare SA Mergers Acquisitions MA, Partnerships Alliances and Investments repo...

Helsinn: Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center

Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Cen...

New formulation of Helsinn's Akynzeo OK'd by FDA

The FDA approved Helsinn's intravenous formulation of Akynzeo, or fosnetupitant and palonosetron, in combination with dexamet -More- 

Helsinn and CJ Healthcare announce the approval of AKYNZEO® oral formulation in Korea

Helsinn and CJ Healthcare announce the approval of AKYNZEO® oral formulation in Korea CINV is one of the most common and distressing side effects of cancer chemotherapyIncluded as a treatment opti...

Press Release: Helsinn Group and MEI Pharma -2-

Press Release: Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatmen...

Helsinn gets global Valchlor/Ledaga rights from Actelion

Johnson & Johnson division Actelion Pharmaceuticals Ltd. granted Helsinn Group global rights to market the topical skin cancer drug Valchlor/Ledaga (mechlorethamine). Financial terms were not disclose...

Helsinn to acquire global rights of Valchlor/Ledaga from Actelion Pharmaceuticals

Helsinn has agreed to acquire worldwide rights to Valchlor/Ledaga (mechlorethamine/chlormethine), an alkylating agent for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-...

Mundipharma & Helsinn expand licensing and distribution agreement to include Vietnam

Mundipharma and Helsinn Group have extended their licensing and distribution agreement for the anti-emetic agent ALOXI to now include Vietnam.

Drugs and Medications [446 Associated Drugs and Medications listed on BioPortfolio]

Bacti-stat [Ecolab Inc.]

Drug Facts

Oxygen [Mon HealthCare]

oxygen

Isagel [Coloplast Manufacturing US, LLC]

Isagel HandwashingNo-Rinse, Antiseptic Hand Cleansing Gel with Added Moisturizers

Endure 200 [Ecolab Inc.]

Drug Facts

Tiger balm [Haw Par Healthcare Ltd.]

TIGER BALM PAIN RELIEVING LARGE PATCH

PubMed Articles [1006 Associated PubMed Articles listed on BioPortfolio]

The Second Society for Simulation in Healthcare Research Summit: Beyond our Boundaries.

In this article, we report on the Second Society for Simulation in Healthcare Research Summit held in 2017. This meeting succeeded the First Research Summit from 2011 with the goal of advancing the sc...

Stress Among Healthcare Professionals Calls Out for Attention.

PRACTITIONER APPLICATION: Innovative Leadership Initiatives to Reduce the Cost of Healthcare.

Healthcare personnel exposure in an emergency department during influenza season.

Healthcare personnel are at high risk for exposure to influenza by direct and indirect contact, droplets and aerosols, and by aerosol generating procedures. Information on air and surface influenza co...

Healthcare use for children with complex needs: using routine health data linked to a multiethnic, ongoing birth cohort.

Congenital anomaly (CA) are a leading cause of disease, death and disability for children throughout the world. Many have complex and varying healthcare needs which are not well understood. Our aim wa...

Clinical Trials [1072 Associated Clinical Trials listed on BioPortfolio]

My Life, My Healthcare

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare t...

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care

Recently, we generated a new multidisciplinary ubiquitous healthcare system by upgrading our clinical decision supporting system (CDSS) rule engine, and integrating a physical activity-mon...

Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel

The purpose of the study on the Prevention of Influenza and Other Wintertime Respiratory Viruses among Healthcare Professionals in Israel Effectiveness of Influenza Vaccine in Preventing I...

Implementation of Medical Weight Management by Telemedicine

As the prevalence and associated healthcare costs of obesity continue to increase, the need for obesity treatments that contribute to weight loss maintenance are needed. Through the functi...

Companies [1816 Associated Companies listed on BioPortfolio]

HELSINN HEALTHCARE S.A.

Helsinn's strategy is focused on three activities Integrated Licensing Helsinn uses an innovative approach to develop and market new pharmaceutical products:INTEGRATED LICENSINGHelsinn adds scient...

Helsinn Healthcare SA

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and subsidiaries in USA and Ireland. Helsinn's unique business model is focused on the licensing of phar...

Helsinn Group and DARA BioSciences, Inc.

Helsinn is a privately owned pharmaceutical group with headquarters in Lugano, Switzerland, and operating subsidiaries in Ireland and the United States. Helsinn’s business mo...

Zelis™ Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

Zelis Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

More Information about "HELSINN HEALTHCARE S.A." on BioPortfolio

We have published hundreds of HELSINN HEALTHCARE S.A. news stories on BioPortfolio along with dozens of HELSINN HEALTHCARE S.A. Clinical Trials and PubMed Articles about HELSINN HEALTHCARE S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HELSINN HEALTHCARE S.A. Companies in our database. You can also find out about relevant HELSINN HEALTHCARE S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record